Study of Gralise to Treat Fibromyalgia Patients

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Fibromyalgia
Interventions
DRUG

Gabapentin ER

"Patient who are on gralise will report efficacy by rating his or her pain rating on a digital pain scale (11 points) from 0 to 10 on each scheduled clinical visits, which will be compared to their pain level at baseline.~In addition, patients will also record the doses and any adverse effects that might arise during the trial in a diary provided by the study. All information will be recorded in a paper diary that will be followed by coordinator during each follow up visits."

Trial Locations (1)

27103

Center for Clinical Research, Winston-Salem

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Depomed

INDUSTRY

lead

The Center for Clinical Research, Winston-Salem, NC

OTHER

NCT02052414 - Study of Gralise to Treat Fibromyalgia Patients | Biotech Hunter | Biotech Hunter